Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jianxin Xue, MD. Phd
CONTACT
You Lu, MD. PhD
CONTACT
Lead
Sichuan University
All eligible patients will receive LDRT combined with partial SBRT, followed by PD-1 inhibitors plus platinum-based chemotherapy, initiated within 7 days after completing radiation. PD-1 inhibitors and chemotherapy will be administered at the recommended doses according to the instruction manual every 3 weeks, with 3 cycles planned as neoadjuvant therapy. Surgery will be performed within 4 to 6 weeks (+7 days) after completing the final cycle of immunochemotherapy. Main objective and endpoint: the rate of pathological complete response (pCR) in the resected primary tumor and lymph nodes.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
